Published in Am J Cardiol on September 15, 1993
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Effect of adjustable passive constraint on the failing left ventricle: a finite-element model study. Ann Thorac Surg (2010) 1.76
Simple area-based measurement for multidetector computed tomography to predict left ventricular size. Eur Radiol (2010) 1.59
Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging. Int J Cardiovasc Imaging (2014) 1.44
Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc (2013) 1.09
Computational method for identifying and quantifying shape features of human left ventricular remodeling. Ann Biomed Eng (2009) 1.08
QTL mapping in a mouse model of cardiomyopathy reveals an ancestral modifier allele affecting heart function and survival. Mamm Genome (2005) 1.03
Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol (2005) 1.01
Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.90
Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc (2014) 0.86
Postmyocardial infarction left ventricular dysfunction - assessment and follow up of patients undergoing surgical ventricular restoration by the endoventricular patchplasty. Indian Heart J (2012) 0.81
Surgical aspects of congestive heart failure. Heart Fail Rev (2006) 0.80
Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function. Eur J Nucl Med Mol Imaging (2009) 0.80
The role of echocardiography in the diagnosis and management of heart failure. Heart Fail Rev (2003) 0.80
Who has advanced heart failure?: definition and epidemiology. Congest Heart Fail (2011) 0.77
Echocardiography predicts adverse cardiac remodelling in heart failure. Exp Clin Cardiol (2004) 0.75
Association between cardiothoracic ratio, left ventricular size and systolic function in patients undergoing computed tomography coronary angiography. Exp Ther Med (2014) 0.75
Clinical characteristics and echocardiographic features of black men vs. black women with systolic heart failure. J Natl Med Assoc (2005) 0.75
CRT in Patients with Heart Failure: Time Course of Perfusion and Wall Motion Changes. Cardiol Res Pract (2010) 0.75
Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction. Circ Heart Fail (2016) 0.75
Elongation as a new shape index for the left ventricle. Int J Cardiovasc Imaging (2002) 0.75
Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats. Pflugers Arch (2007) 0.75
Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep (2017) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A (1980) 4.66
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 3.80
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest (1991) 3.07
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol (2000) 2.99
Self-study from web-based and printed guideline materials. A randomized, controlled trial among resident physicians. Ann Intern Med (2000) 2.40
Quantification of flow through an interatrial communication. Application to the partial Fontan procedure. J Thorac Cardiovasc Surg (1992) 2.39
Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med (1997) 2.39
Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol (1997) 2.35
The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol (2001) 2.33
Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation (2001) 2.29
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation (2000) 2.22
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res (2000) 2.22
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J (2000) 1.94
The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J (1999) 1.94
Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant (2001) 1.92
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J (1999) 1.90
Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts. J Thorac Cardiovasc Surg (1990) 1.88
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest (1988) 1.76
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol (1998) 1.70
Benefits of early surgical repair in fixed subaortic stenosis. J Am Coll Cardiol (1997) 1.68
Secondary preventive medication persistence and adherence 1 year after stroke. Neurology (2011) 1.62
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation (1989) 1.61
The Postoperative Morbidity Survey was validated and used to describe morbidity after major surgery. J Clin Epidemiol (2007) 1.60
Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol (1991) 1.57
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Coronary sinus ostial occlusion during retrograde delivery of cardioplegic solution significantly improves cardioplegic distribution and efficacy. J Thorac Cardiovasc Surg (1995) 1.55
Total cavopulmonary anastomosis versus conventional modified Fontan procedure. Ann Thorac Surg (1991) 1.50
Comparison of thermodilution and transthoracic electrical bioimpedance cardiac outputs. Heart Lung (1991) 1.47
Quality of life in patients with advanced heart failure. J Heart Lung Transplant (1992) 1.47
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation (1997) 1.46
Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J Thorac Cardiovasc Surg (1997) 1.46
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest (1997) 1.45
Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg (1993) 1.43
Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia. J Thorac Cardiovasc Surg (1993) 1.42
Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study. Circulation (1995) 1.41
Recognition of the Wenckebach phenomenon. West J Med (1978) 1.40
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
The heterotopic right heart assist transplantation. J Heart Transplant (1988) 1.39
The current role of left ventricular reduction for treatment of heart failure. J Am Coll Cardiol (1998) 1.39
Inotropic therapy for heart failure. N Engl J Med (1998) 1.39
Interval estimation of the density of organisms using a serial-dilution experiment. Biometrics (1984) 1.37
Factors influencing survival in patients undergoing the bidirectional Glenn anastomosis. Am J Cardiol (1995) 1.37
Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. J Am Coll Cardiol (1986) 1.36
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation (1995) 1.32
Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med (1988) 1.30
Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol (1995) 1.29
The influence of coronary anatomy on the arterial switch operation in neonates. J Thorac Cardiovasc Surg (1992) 1.28
Exaggerated muscle mechanoreflex control of reflex renal vasoconstriction in heart failure. J Appl Physiol (1985) (2001) 1.26
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol (2001) 1.26
Incidence and significance of early pericardial effusions after cardiac surgery. Am J Cardiol (1984) 1.26
Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest (1990) 1.25
Systemic venous and pulmonary arterial flow patterns after Fontan's procedure for tricuspid atresia or single ventricle. Circulation (1984) 1.24
Sudden death prevention in patients with advanced ventricular dysfunction. Circulation (1993) 1.23
Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant (1999) 1.23
Multiple left heart obstructions (Shone's anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg (1997) 1.22
Long-term results following correction of esophageal atresia with tracheoesophageal fistula: a clinical and cinefluorographic study. J Pediatr Surg (1973) 1.22
Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol (1993) 1.20
Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology (1987) 1.20
Choosing the parameter for a 2 x 2 table or a 2 x 2 x 2 table analysis. Am J Epidemiol (1979) 1.20
Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol (1994) 1.19